Matches in Wikidata for { <http://www.wikidata.org/entity/Q91366164> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q91366164 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q91366164 description "scientific article published on 20 August 2018" @default.
- Q91366164 description "wetenschappelijk artikel" @default.
- Q91366164 description "наукова стаття, опублікована в серпні 2018" @default.
- Q91366164 name "Corrigendum to "Chitosan-coated liposome dry-powder formulations loaded with ghrelin for nose-to-brain delivery" [Eur. J. Pharm. Biopharm. 129 (2018) 257-266]" @default.
- Q91366164 name "Corrigendum to "Chitosan-coated liposome dry-powder formulations loaded with ghrelin for nose-to-brain delivery" [Eur. J. Pharm. Biopharm. 129 (2018) 257-266]" @default.
- Q91366164 type Item @default.
- Q91366164 label "Corrigendum to "Chitosan-coated liposome dry-powder formulations loaded with ghrelin for nose-to-brain delivery" [Eur. J. Pharm. Biopharm. 129 (2018) 257-266]" @default.
- Q91366164 label "Corrigendum to "Chitosan-coated liposome dry-powder formulations loaded with ghrelin for nose-to-brain delivery" [Eur. J. Pharm. Biopharm. 129 (2018) 257-266]" @default.
- Q91366164 prefLabel "Corrigendum to "Chitosan-coated liposome dry-powder formulations loaded with ghrelin for nose-to-brain delivery" [Eur. J. Pharm. Biopharm. 129 (2018) 257-266]" @default.
- Q91366164 prefLabel "Corrigendum to "Chitosan-coated liposome dry-powder formulations loaded with ghrelin for nose-to-brain delivery" [Eur. J. Pharm. Biopharm. 129 (2018) 257-266]" @default.
- Q91366164 P1433 Q91366164-B5B24BBF-3BF1-4738-A990-8B06568877C2 @default.
- Q91366164 P1476 Q91366164-BA176617-DEC9-4A30-BBA3-0CFE3CFBEB01 @default.
- Q91366164 P2093 Q91366164-6250E12A-7DB9-4CCC-95A5-7A855C22D642 @default.
- Q91366164 P2093 Q91366164-6D70AEA6-D72A-4F23-B48B-82DD0231D333 @default.
- Q91366164 P2093 Q91366164-ACBB35A1-B554-40D7-AB3C-FDA2EC9AB19A @default.
- Q91366164 P2093 Q91366164-BC59129A-E199-42E3-BDDD-ADD47BF8E4F1 @default.
- Q91366164 P2093 Q91366164-E98B3B84-8E70-479E-8BFF-F45593BE26F6 @default.
- Q91366164 P304 Q91366164-9469DF54-1BFF-4633-BFEB-C567FFC3340D @default.
- Q91366164 P31 Q91366164-45C2770D-B543-4797-9C91-23A78DC55B03 @default.
- Q91366164 P31 Q91366164-8854CE75-C8F3-432D-8AC4-4E44D2DC6E62 @default.
- Q91366164 P356 Q91366164-FF75D205-32C8-4556-9A9D-00315047F93E @default.
- Q91366164 P478 Q91366164-4AB38EC1-4AE0-4933-AA87-B411DA54E4EF @default.
- Q91366164 P577 Q91366164-2C12CC79-FFA1-45D2-AABB-DDADE805D3B8 @default.
- Q91366164 P698 Q91366164-A564DC38-BB0A-4538-9407-1D4A2706CD94 @default.
- Q91366164 P356 J.EJPB.2018.08.005 @default.
- Q91366164 P698 30201099 @default.
- Q91366164 P1433 Q5412740 @default.
- Q91366164 P1476 "Corrigendum to "Chitosan-coated liposome dry-powder formulations loaded with ghrelin for nose-to-brain delivery" [Eur. J. Pharm. Biopharm. 129 (2018) 257-266]" @default.
- Q91366164 P2093 "Jonathan Goole" @default.
- Q91366164 P2093 "Karim Amighi" @default.
- Q91366164 P2093 "Laurent Salade" @default.
- Q91366164 P2093 "Marjorie Vermeersch" @default.
- Q91366164 P2093 "Nathalie Wauthoz" @default.
- Q91366164 P304 "151" @default.
- Q91366164 P31 Q13442814 @default.
- Q91366164 P31 Q1348305 @default.
- Q91366164 P356 "10.1016/J.EJPB.2018.08.005" @default.
- Q91366164 P478 "131" @default.
- Q91366164 P577 "2018-08-20T00:00:00Z" @default.
- Q91366164 P698 "30201099" @default.